![Frederick Sancilio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frederick Sancilio
Vorstandsvorsitzender bei
LOBE SCIENCES LTD.
Vermögen: 9 Mio $ am 31.05.2026
Profil
Frederick D.
Sancilio is the founder.
Founded AAIPharma, Inc. in 1977 as Chief Executive Officer.
Founded Sancilio Pharmaceuticals Co., Inc. in 2004 as Chairman, President & Chief Executive Officer.
Founded Sancilio & Co., Inc. in 2005 as Director.
Dr. Sancilio is also the founder of Endeavor Pharmaceuticals, Inc., Aesgen, Inc., Applied Analytical Industries, Inc., TrippBio, Inc. Current job at Lobe Sciences Ltd. as Chairman & Chief Executive Officer since 2024.
Former job at Aptiv Solutions, Inc. as Vice Chairman.
Former job at IT&E International Group, Inc. as Director in 2006.
Former job at Alpha Cognition, Inc. as Director & Head-Production Development.
Former job at Alpha Cognition, Inc. as President & Director in 2021.
Former job at Florida Atlantic University as Research Professor.
Former job at Sigma XI as Member.
Education at Rutgers State University of New Jersey with graduate and doctorate degrees.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LOBE SCIENCES LTD 41.42% | 31.08.2025 | 117’666’773 ( 41.42% ) | 9 Mio $ | 31.05.2026 |
Aktive Positionen von Frederick Sancilio
| Unternehmen | Position | Beginn |
|---|---|---|
| LOBE SCIENCES LTD. | Vorstandsvorsitzender | 12.08.2024 |
Sancilio & Co., Inc.
 Sancilio & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides Lipidology an emerging field of clinical and non-clinical pharmaceutical research. | Gründer | 01.01.2005 |
TrippBio, Inc.
 TrippBio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Gründer | - |
Ehemalige bekannte Positionen von Frederick Sancilio
| Unternehmen | Position | Ende |
|---|---|---|
| ALPHA COGNITION INC. | Präsident | 27.12.2021 |
IT&E International Group, Inc.
 IT&E International Group, Inc. Financial ConglomeratesFinance Development stage company | Direktor/Vorstandsmitglied | 22.09.2006 |
AAIPharma, Inc.
 AAIPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides product development services to the pharmaceutical, biotechnology and medical device industries | Vorstandsvorsitzender | 01.01.2002 |
Applied Analytical Industries, Inc.
 Applied Analytical Industries, Inc. BiotechnologyHealth Technology Researches and develops pharmaceutical products | Gründer | - |
Sigma XI
 Sigma XI Miscellaneous Commercial ServicesCommercial Services Operates as science and engineering professional organization | Corporate Officer/Principal | - |
Ausbildung von Frederick Sancilio
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
AAIPharma, Inc.
AAIPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides product development services to the pharmaceutical, biotechnology and medical device industries | Commercial Services |
Endeavor Pharmaceuticals, Inc.
 Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hormone replacement pharmaceutical products | Health Technology |
IT&E International Group, Inc.
IT&E International Group, Inc. Financial ConglomeratesFinance Development stage company | Finance |
Applied Analytical Industries, Inc.
Applied Analytical Industries, Inc. BiotechnologyHealth Technology Researches and develops pharmaceutical products | Health Technology |
Aesgen, Inc.
 Aesgen, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Florida Atlantic University
 Florida Atlantic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Averion International Corp.
 Averion International Corp. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
Sigma XI
Sigma XI Miscellaneous Commercial ServicesCommercial Services Operates as science and engineering professional organization | Commercial Services |
Sancilio & Co., Inc.
Sancilio & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides Lipidology an emerging field of clinical and non-clinical pharmaceutical research. | Commercial Services |
Sancilio Pharmaceuticals Co., Inc.
 Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures pharmaceutical products | Commercial Services |
Alpha Cognition, Inc. /old/
 Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treating alzheimer disease and amyotrophic lateral sclerosis | Health Technology |
Lobe Sciences Ltd.
 Lobe Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries develops patented drug candidates to treat chronic cluster headache | Health Technology |
TrippBio, Inc.
TrippBio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Alpha Cognition, Inc.
 Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
